# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Management call scheduled for Monday, June 3, 2024 at 8:30 AM ETCRANFORD, N.J., May 29, 2024 /PRNewswire/ -- Citius Pharmaceuti...
Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infecti...
Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.13...